FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

708097004: Immunohistochemistry technique (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2015. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3033004017 Immunohistochemistry en Synonym Active Entire term case insensitive SNOMED CT core module
3034678011 Immunohistochemistry technique en Synonym Active Entire term case insensitive SNOMED CT core module
3034685010 Immunohistochemistry technique (qualifier value) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Immunohistochemistry technique Is a Technique true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Presence of receptor tyrosine-protein kinase erbB-2 in primary malignant neoplasm of breast by immunohistochemistry Technique True Immunohistochemistry technique Inferred relationship Existential restriction modifier 1
Status of estrogen receptor stain in control cells by immunohistochemistry Technique True Immunohistochemistry technique Inferred relationship Existential restriction modifier 1
Status of progesterone receptor stain in control cells by immunohistochemistry Technique True Immunohistochemistry technique Inferred relationship Existential restriction modifier 1
Presence of progesterone receptor in primary malignant neoplasm of breast by immunohistochemistry Technique True Immunohistochemistry technique Inferred relationship Existential restriction modifier 2
Percent of cells with progesterone receptor in primary malignant neoplasm of breast by immunohistochemistry Technique True Immunohistochemistry technique Inferred relationship Existential restriction modifier 2
Percent of cells with estrogen receptor in primary malignant neoplasm of breast by immunohistochemistry Technique True Immunohistochemistry technique Inferred relationship Existential restriction modifier 2
Presence of estrogen receptor in primary malignant neoplasm of breast by immunohistochemistry Technique True Immunohistochemistry technique Inferred relationship Existential restriction modifier 2
Intensity of stain of estrogen receptor in primary malignant neoplasm of breast by immunohistochemistry Technique True Immunohistochemistry technique Inferred relationship Existential restriction modifier 2
Observation using immunohistochemistry Technique True Immunohistochemistry technique Inferred relationship Existential restriction modifier 1
Intensity of stain of progesterone receptor in primary malignant neoplasm of breast by immunohistochemistry Technique True Immunohistochemistry technique Inferred relationship Existential restriction modifier 2
Percent of cell nuclei positive for proliferation marker protein Ki-67 in primary malignant neoplasm of breast by immunohistochemistry Technique True Immunohistochemistry technique Inferred relationship Existential restriction modifier 2
Presence of DNA mismatch repair protein Msh2 in primary malignant neoplasm of colon by immunohistochemistry Technique True Immunohistochemistry technique Inferred relationship Existential restriction modifier 2
Presence of DNA mismatch repair protein Msh6 in primary malignant neoplasm of colon by immunohistochemistry Technique True Immunohistochemistry technique Inferred relationship Existential restriction modifier 2
Presence of ALK tyrosine kinase receptor in primary malignant neoplasm of lung by immunohistochemistry Technique True Immunohistochemistry technique Inferred relationship Existential restriction modifier 2
Presence of proto-oncogene tyrosine-protein kinase ROS in primary malignant neoplasm of lung by immunohistochemistry Technique True Immunohistochemistry technique Inferred relationship Existential restriction modifier 2
Presence of mismatch repair endonuclease PMS2 in primary malignant neoplasm of endometrium by immunohistochemistry Technique True Immunohistochemistry technique Inferred relationship Existential restriction modifier 2
Presence of DNA mismatch repair protein Msh6 in primary malignant neoplasm of endometrium by immunohistochemistry Technique True Immunohistochemistry technique Inferred relationship Existential restriction modifier 2
Presence of estrogen receptor in primary malignant neoplasm of endometrium by immunohistochemistry Technique True Immunohistochemistry technique Inferred relationship Existential restriction modifier 2
Presence of receptor tyrosine-protein kinase erbB-2 in primary malignant neoplasm of endometrium by immunohistochemistry Technique True Immunohistochemistry technique Inferred relationship Existential restriction modifier 2
Percent of cell nuclei positive for proliferation marker protein Ki-67 in primary malignant neoplasm of appendix by immunohistochemistry Technique True Immunohistochemistry technique Inferred relationship Existential restriction modifier 2
Presence of progesterone receptor in primary malignant neoplasm of endometrium by immunohistochemistry Technique True Immunohistochemistry technique Inferred relationship Existential restriction modifier 2
Percent of cell nuclei positive for proliferation marker protein Ki-67 in primary malignant neoplasm of adrenal gland by immunohistochemistry Technique True Immunohistochemistry technique Inferred relationship Existential restriction modifier 2
Presence of DNA mismatch repair protein Mlh1 in primary malignant neoplasm of endometrium by immunohistochemistry Technique True Immunohistochemistry technique Inferred relationship Existential restriction modifier 2
Presence of DNA mismatch repair protein Mlh1 in primary malignant neoplasm of lung by immunohistochemistry Technique True Immunohistochemistry technique Inferred relationship Existential restriction modifier 2
Percent of cell nuclei positive for proliferation marker protein Ki-67 in primary malignant neoplasm of small intestine by immunohistochemistry Technique True Immunohistochemistry technique Inferred relationship Existential restriction modifier 2
Presence of mismatch repair endonuclease PMS2 in primary malignant neoplasm of lung by immunohistochemistry Technique True Immunohistochemistry technique Inferred relationship Existential restriction modifier 2
Presence of mismatch repair endonuclease PMS2 in primary malignant neoplasm of colon by immunohistochemistry Technique True Immunohistochemistry technique Inferred relationship Existential restriction modifier 2
Presence of DNA mismatch repair protein Msh2 in primary malignant neoplasm of lung by immunohistochemistry Technique True Immunohistochemistry technique Inferred relationship Existential restriction modifier 2
Presence of DNA mismatch repair protein Mlh1 in primary malignant neoplasm of colon by immunohistochemistry Technique True Immunohistochemistry technique Inferred relationship Existential restriction modifier 2
Percent of cell nuclei positive for proliferation marker protein Ki-67 in primary malignant neoplasm of stomach by immunohistochemistry Technique True Immunohistochemistry technique Inferred relationship Existential restriction modifier 2
Presence of programmed cell death 1 ligand 1 in primary malignant neoplasm of lung by immunohistochemistry Technique True Immunohistochemistry technique Inferred relationship Existential restriction modifier 2
Presence of DNA mismatch repair protein Msh2 in primary malignant neoplasm of endometrium by immunohistochemistry Technique True Immunohistochemistry technique Inferred relationship Existential restriction modifier 2
Presence of DNA mismatch repair protein Msh6 in primary malignant neoplasm of lung by immunohistochemistry Technique True Immunohistochemistry technique Inferred relationship Existential restriction modifier 2
Presence of receptor tyrosine-protein kinase erbB-2 in primary malignant neoplasm of lung by immunohistochemistry Technique True Immunohistochemistry technique Inferred relationship Existential restriction modifier 2
Percent of cell nuclei positive for proliferation marker protein Ki-67 in primary malignant neoplasm by immunohistochemistry Technique True Immunohistochemistry technique Inferred relationship Existential restriction modifier 2
Percent of cell nuclei positive for proliferation marker protein Ki-67 in primary malignant neoplasm of pancreas by immunohistochemistry Technique True Immunohistochemistry technique Inferred relationship Existential restriction modifier 2
Presence of anoctamin-1 in primary gastrointestinal stromal sarcoma by immunohistochemistry Technique True Immunohistochemistry technique Inferred relationship Existential restriction modifier 2
Presence of mast/stem cell growth factor receptor Kit in primary gastrointestinal stromal sarcoma by immunohistochemistry Technique True Immunohistochemistry technique Inferred relationship Existential restriction modifier 2
Presence of succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial in primary gastrointestinal stromal sarcoma by immunohistochemistry Technique True Immunohistochemistry technique Inferred relationship Existential restriction modifier 2
Presence of succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial in primary gastrointestinal stromal sarcoma by immunohistochemistry Technique True Immunohistochemistry technique Inferred relationship Existential restriction modifier 2

This concept is not in any reference sets

Back to Start